Sanofi Contingent Liabilities Recognised In Business Combination
Sanofi (SNYNF) had Contingent Liabilities Recognised In Business Combination of EUR 585.00 million as of 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination · last filed 2026-02-17
- 2025-12-31: Contingent Liabilities Recognised In Business Combination 585.00M EUR.
- 2025-06-30: Contingent Liabilities Recognised In Business Combination 564.00M EUR.
- 2024-12-31: Contingent Liabilities Recognised In Business Combination 641.00M EUR.
- 2024-06-30: Contingent Liabilities Recognised In Business Combination 728.00M EUR.
| Period end | Contingent Liabilities Recognised In Business Combination |
|---|---|
| 2025-12-31 | 585.00M EUR 20-F · filed 2026-02-17 |
| 2025-06-30 | 564.00M EUR 6-K · filed 2025-10-27 |
| 2024-12-31 | 641.00M EUR 20-F · filed 2026-02-17 |
| 2024-06-30 | 728.00M EUR 6-K · filed 2024-07-25 |
| 2023-12-31 | 709.00M EUR 20-F · filed 2026-02-17 |
| 2023-06-30 | 717.00M EUR 6-K · filed 2023-07-28 |
| 2022-12-31 | 779.00M EUR 20-F · filed 2026-02-17 |
| 2022-06-30 | 832.00M EUR 6-K · filed 2022-07-28 |
| 2021-12-31 | 714.00M EUR 20-F · filed 2025-02-13 |
| 2021-06-30 | 447.00M EUR 6-K · filed 2021-07-29 |
| 2020-12-31 | 605.00M EUR 20-F · filed 2024-02-23 |
| 2020-06-30 | 656.00M EUR 6-K · filed 2020-07-29 |
| 2019-12-31 | 800.00M EUR 20-F · filed 2023-02-24 |
| 2018-12-31 | 1.30B EUR 20-F · filed 2022-02-23 |
| 2017-12-31 | 1.37B EUR 20-F · filed 2021-03-04 |
| 2016-12-31 | 1.58B EUR 20-F · filed 2020-03-05 |
| 2015-12-31 | 1.25B EUR 20-F · filed 2019-03-08 |
| 2014-12-31 | 1.26B EUR 20-F/A · filed 2018-03-16 |